| Bioactivity | (R)-(+)-Trityl glycidyl ether, a heterocyclic compound, is a precursor that can be used to synthesize glycerophospholipids, as well as compounds with antiviral and antimalarial activities[1][2]. | ||||||||||||
| CAS | 65291-30-7 | ||||||||||||
| Formula | C22H20O2 | ||||||||||||
| Molar Mass | 316.39 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Baszczyňski O, et al. Synthesis and antiviral activity of N9-[3-fluoro-2-(phosphonomethoxy)propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurines. Bioorg Med Chem. 2011 Apr 1;19(7):2114-24. [2]. Sato E, et al. Design, synthesis and anti-malarial activities of synthetic analogs of biselyngbyolide B, a Ca2+ pump inhibitor from marine cyanobacteria. Bioorg Med Chem Lett. 2018 Feb 1;28(3):298-301. |
(R)-(+)-Trityl glycidyl ether
CAS: 65291-30-7 F: C22H20O2 W: 316.39
(R)-(+)-Trityl glycidyl ether, a heterocyclic compound, is a precursor that can be used to synthesize glycerophospholipi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.